Vitamin D deficiency: Subclinical and clinical consequences on musculoskeletal health

Current Rheumatology Reports

Volumn 14, Issue 3, 2012, Pages 286-293

  Haroon, Muhammad ^a   FitzGerald, Oliver ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Chronic pain; Deficiency; Fall; Inflammation; Muscle; Musculoskeletal health; Osteomalacia; Vitamin D

Indexed keywords

HORMONE RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

AGE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; BONE GROWTH; CD4+ T LYMPHOCYTE; CHRONIC PAIN; DISEASE SEVERITY; DNA POLYMORPHISM; FALLING; HUMAN; INFLAMMATION; MUSCLE DISEASE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULOSKELETAL FUNCTION; MYOPATHY; OSTEOMALACIA; PLEIOTROPY; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SKELETAL MUSCLE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACCIDENTAL FALLS; CHRONIC PAIN; HUMANS; MUSCLE, SKELETAL; MUSCULOSKELETAL DISEASES; OSTEOMALACIA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84860777796     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0244-8     Document Type: Review

References (105)

1. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC. 1,25(OH)2D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol. 1992;41:231-40.
2. Hausler MR, Myrtle JF, Norman AW. The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem. 1968;243:4055-64.
3. Norman AW, Bishop JE, Bula CM, Olivera CJ, Mizwicki MT, Zanello LP, Ishida H, Okamura WH. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1alpha,25(OH)2-vitaminD3. Steroids. 2002;67:457-66. (Pubitemid 34311760)
4. Holick MF. Non-calcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone. 1995;17:S107-11.
5. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. The vitamin D receptor is present in caveolae enriched plasma membranes and binds 1alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol. 2004;18:2660-71. (Pubitemid 39482056)
6. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D deficiency. Lancet. 1998;351(9105):805-6.
7. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: a means to determining hypovitaminosis D. Osteoporos Int. 1998;8:S3-6. (Pubitemid 28416848)
8. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357 (3):266-81.
9. Hollis BW, Wagner SL. Vitamin D deficiency during pregnancy: an ongoing epidemic. Am J Clin Nutr. 2006;84:272.
10. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr. 1999;69:842-56. (Pubitemid 29205056)
11. Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93-101.
12. Bhalla AK, Amento EP, Serog B, et al. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984;133:1748-54. (Pubitemid 14035260)
13. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992;49:26-31.
14. Mattner F, Smiroldo S, Galbiati F, et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25- dihydroxyvitamin D(3). Eur J Immunol. 2000;30:498-508. (Pubitemid 30098842)
15. Boonstra A, Barrat FJ, Crain C, et al. 1>25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974-80. (Pubitemid 33009728)
16. Deluca HF, Cantorna M. Vitamin D: its role and uses in immunology. FASEB J. 2001;15:2579-85. (Pubitemid 33131084)
17. Berer A, Stockl J, Majdic O, et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol. 2000;28:575-83. (Pubitemid 30254459)
18. Penna G, Adorini L. 1>25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164:2405-11. (Pubitemid 30115468)
19. Griffin MD, Lutz WH, Phan VA, et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000;270:701-8. (Pubitemid 30444768)
20. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88(5):441-50.
21. Linker-Israeli M, Elstner E, Klinenberg JR, et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001;99:82-93.
22. Cutolo M, Otsa K, Laas K, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2006;24:702-4. (Pubitemid 46138805)
23. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56:2143-9. (Pubitemid 47173561)
24. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol. 2010 Oct 26. [Epub ahead of print].
25. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010;5(2):e9193.
26. Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis. 2010;69(6):1155-7.
27. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116(8):2062-72. (Pubitemid 44162310)
28. Frances RM, Selby PL. Osteomalacia. Ballieres Clin Endocrinol. 1997;11:145-63. (Pubitemid 27309773)
29. Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A. Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin Arthritis Rheum. 1999;28(5):287-304. Review. (Pubitemid 29211372)
30. Nelson AM, Riggs BL, Jowsey JO. Atypical axial osteomalacia: report of four cases with two having features of ankylosing spondylitis. Arthritis Rheum. 1978;21:715-9.
31. Polisson RP, Martinez S, Khoury M, et al. Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N Engl J Ned. 1985;313:1-6. (Pubitemid 15068736)
32. Dent CE, Hat SM. Hereditary forms of rickets and osteomalacia. J Bone Joint Surg. 1956;38:204-26.
33. Whyte ME, Fallon MD, Murphy WA, et al. Axial osteomalacia. Am J Med. 1981;71:1041-9.
34. Al-Said YA, Al-Rachad HS, Al-Qahtani HA, Jan MM. Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci. 2009;36(3):336-9.
35. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med. 2000;160(8):1199-203. (Pubitemid 30227032)
36. Karia J, Katiyar BC, Srivastava TP, Dube B. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand. 1975;51:37-58.
37. Campbell GA, Kemm JR, Hosking DJ, Boyd RV. How common is osteomalacia in the elderly? Lancet. 1984;2(8399):386-8. (Pubitemid 14059317)
38. Tucker GS, Middha VP, Sural A, Sagreiya K. Incidence of osteomalacia in fractures of the proximal end of femur. Injury. 1988;19(2):89-92. (Pubitemid 18092842)
39. Pettifor JM, Isdale JM, Sahakian J, Hansen JD. Diagnosis of subclinical rickets. Arch Dis Child. 1980;55(2):155-7. (Pubitemid 10133716)
40. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet. 1976;1(7960):626-9.
41. Prineas JW, Mason AS, Henson RA. Myopathy in metabolic bone disease. Br Med J. 1965;1(5441):1034-6.
42. Boullion R, Carmeliet G, Daci E, et al. Vitamin D metabolism and action. Osteoporos Int. 1998;8 Suppl 2:S13-9. (Pubitemid 28416850)
43. Boland R. Role of vitamin D in skeletal muscle function. Endocrinol Rev. 1986;7(4):434-48.
44. Ekbom K, Hed R, Kirstein L, Astroem KE. Weakness of proximal limb muscles, probably due to myopathy after partial gastrectomy. Preliminary report. Acta Med Scand. 1964;176:493-6.
45. Smith R, Stern G. Myopathy, osteomalacia and hyperparathyroidism. Brain. 1967;90(3):593-602.
46. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25- dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260(15):8882-91. (Pubitemid 15011982)
47. Costa EM, Blau HM, Feldman D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology. 1986;119(5):2214-20. (Pubitemid 17171405)
48. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly non-obese women. J Bone Miner Res. 1997;12:2082-8. (Pubitemid 27524485)
49. Visser M, Deeg DJ, Lips P, et al. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766-72. (Pubitemid 38033048)
50. Joborn C, Joborn H, Rastad J, Akerström G, Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg. 1988;75 (1):77-80. (Pubitemid 18055607)
51. Kristoffersson A, Boström A, Söderberg T. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg. 1992;79(2):165-8.
52. Garber AJ. Effect of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J Clin Invest. 1983;71:1806-21. (Pubitemid 13056784)
53. Baczynski R, Massry SG, Magott M, el Belbessi S, Kohan R, Brautbar N. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int. 1985;28:722-7. (Pubitemid 16156311)
54. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005;16(11):1425-31. (Pubitemid 41534648)
55. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, Allain TJ. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33 (6):589-95. (Pubitemid 39504292)
56. Bischoff HA, Stahelin HB, Urscheler N. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil. 1999;80:54-8. (Pubitemid 29035822)
57. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Mineral Res. 2000;15:1113-18. (Pubitemid 30350073)
58. Lord SR, Sambrook P, Gilbert C, et al. Postural stability, falls, and fractures in the elderly: results from the Dubbo osteoporosis epidemiology study. Med J Aust. 1994;160:688-91.
59. Nguyen T, Sambrook P, Kelly PJ, et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993; 307:1111-15. (Pubitemid 23313207)
60. • Gilsanz V, Kremer A, Mo AO, Wren TA, Kremer R. Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab. 2010;95(4):1595-601. This recent article reported a significant inverse relation of low vitamin D levels with skeletal muscle fat infiltration in asymptomatic young women, which was noted to be independent of muscle mass. This potentially has an important role in the function of myocytes.
61. Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc. 2003;51(9):1219-26. (Pubitemid 37093570)
62. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S,Ward L, Moher D, Hanley D, FangM, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235.
63. • Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int. 2011;22 (3):859-71. This is a recent up-to-date systematic review examining the role of vitamin D in muscle strength.
64. Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, Uppal M, Khanal S. Low serum 25 (OH) vitamin D levels
65. Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, Goldenberg N. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin. 2011;27 (9):1683-90. Epub 2011 Jul 6.
66. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319 (26):1701-7. (Pubitemid 19019577)
67. Tromp AM, Smit JH, Deeg DJ, et al. Predictors for falls and fractures in the Longitudinal Aging Study Amsterdam. J Bone Miner Res. 1998;13(12):1932-9. (Pubitemid 28535851)
68. Parkkari J, Kannus P, Palvanen M, et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int. 1999;65(3):183-7. (Pubitemid 29380335)
69. Youm T, Koval KJ, Kummer FJ, Zuckerman JD. Do all hip fractures result from a fall? Am J Orthop. 1999;28(3):190-4.
70. Tinetti ME, Williams CS. The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci. 1998;53(2):M112-9. (Pubitemid 28136149)
71. Stel VS, Smit JH, Pluijm SM, Lips P. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Ageing. 2004;33(1):58-65. (Pubitemid 38111450)
72. Alexander BH, Rivara FP, Wolf ME. The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health. 1992;82:1020-3.
73. Rizzo JA, Baker DI, McAvay G, Tinetti ME. The cost effectiveness of a multifactorial targeted prevention program for falls among community elderly persons. Med Care. 1996;34:954-69. (Pubitemid 126465551)
74. Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999;47:1195-201. (Pubitemid 29473291)
75. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Mineral Res. 2000;15:1113-18. (Pubitemid 30350073)
76. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomised controlled trial. J Bone Mineral Res. 2003;18:343-51. (Pubitemid 36125927)
77. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006. (Pubitemid 38544282)
78. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and alpha-hydroxylated vitamin D: a meta-analysis of randomized controlled trials. BMJ. 2009;339: b3692.
79. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;(2):CD007146.
80. Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59(1):148-57.
81. Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R, Felsenberg D, Glüer C, Roux C, Reid DM. Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int. 2010;21 (3):457-66. Epub 2009 Jul 24.
82. http://www.who.int/violence-injury-prevention/other-injury/ falls/en/index.html.
83. Zecevic AA, Salmoni AW, Speechley M, Vandervoort AA. Defining a fall and reasons for falling: comparisons among the views of seniors, health care providers, and the research literature. Gerontologist. 2006;46(3):367-76. (Pubitemid 43806971)
84. Hauer K, Lamb SE, Jorstad EC, Todd C, Becker C, PROFANEGroup. Systematic review of definitions and methods of measuring falls in randomised controlled fall prevention trials. Age Ageing. 2006;35(1):5-10. (Pubitemid 43124914)
85. Staud R. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol. 2004;16:157-63. (Pubitemid 38280954)
86. Knutsen KV, Brekke M, Gjelstad S, Lagerløv P. Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care. 2010;28(3):166-71.
87. Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine. 2003;28:177-9. (Pubitemid 36110086)
88. Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bodeker RH, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int. 2006;17:1133-40.
89. Benson J, Wilson A, Stocks N, Moulding N. Muscle pain as an indicator of vitamin D deficiency in an urban Australian Aboriginal population. Med J Aust. 2006;185:76-7. (Pubitemid 44164814)
90. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA. HypovitaminosisDin female patientswith chronic low back pain. Clin Rheumatol. 2007;26:1895-901. doi:10.1007/s10067-007-0603-4. (Pubitemid 47516971)
91. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hyppönen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis. 2009;68(6):817-22. Epub 2008 Aug 12.
92. McBeth J, Pye SR, O'Neill TW, Macfarlane GJ, Tajar A, Bartfai G, Boonen S, Bouillon R, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC, EMAS Group. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis. 2010;69(8):1448-52. Epub 2010 May 24.
93. de Rezende Pena C, Grillo LP, das Chagas Medeiros MM. Evaluation of 25-hydroxyvitamin d serum levels in patients with fibromyalgia. J Clin Rheumatol. 2010;16(8):365-9.
94. Warner AE, Arnspiger SA. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol. 2008;14:12-6.
95. Badsha H, Daher M, Ooi KK. Myalgias or non-specific muscle pain in Arab or Indo-Pakistani patients may indicate vitamin D deficiency. Clin Rheumatol. 2009;28:971-3.
96. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;66:419-24. (Pubitemid 30368371)
97. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008;168:771-2. (Pubitemid 351563964)
98. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med. 2000;160:1199-203. (Pubitemid 30227032)
99. Wandless I, Jarvis S, Evans JG, Aird EG, Stevens J. Vitamin D3 in osteoporosis. Br Med J. 1980;280:1320.
100. Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis. J Orthop Sci. 2003;8:532-7. (Pubitemid 37012065)
101. Block SR. Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc. 2004;79:1585-6.
102. Straube S, Andrew Moore R, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain. 2009;141(1-2):10-3.
103. Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007771.
104. Straube S, Moore RA, Derry S, Hallier E, McQuay HJ. Vitamin D and chronic pain in immigrant and ethnic minority patients- investigation of the relationship and comparison with native Western populations. Int J Endocrinol. 2010;2010:753075. Epub 2009 Oct 19.
105. Kragstrup TW. Vitamin D supplementation for patients with chronic pain. Scand J Prim Health Care. 2010 Nov 15. [Epub ahead of print] PMID:21073396.